{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-007513","form_type":"8-K","ticker":"PACB","cik":"0001299130","company_name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","filed_at":"2023-01-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.275909+00:00","generated_at":"2026-06-20T07:05:02.472835+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"PacBio prices 17.5M-share offering at $10/shr; expected net proceeds ~$189.2M","bullets":["Sold 17.5M shares plus full exercise of underwriter option for 2.625M additional shares at $10.00 per share.","Gross proceeds ~$175M before option; net proceeds after discounts/expenses expected ~$189.2M.","Net proceeds to fund R&D, commercial infrastructure, working capital, and potential acquisitions.","Underwriters include Goldman Sachs, Morgan Stanley, Cowen, and Allen & Company; offering closed January 27, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-007513","json":"https://secwatch.observer/filing/0001104659-23-007513.json","markdown":"https://secwatch.observer/filing/0001104659-23-007513.md","text":"https://secwatch.observer/filing/0001104659-23-007513.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1299130/000110465923007513/0001104659-23-007513-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1299130/000110465923007513/tm234462d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T07:05:02.472835+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"822bac5110930dfa817e9cfb0a0de2d71c6166ec","claim":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC. entered into Underwriting Agreement with Goldman Sachs & Co. LLC, Morgan Stanley & Co. LLC, and Cowen and Company, LLC, as representatives of the several underwriters named therein valued at approximately $189.2 million (effective 2023-01-24).","evidence_excerpt":"On January 24, 2023, Pacific Biosciences of California, Inc. (the “ Company ”) entered into an underwriting agreement (the “ Underwriting Agreement ”) with Goldman Sachs & Co. LLC, Morgan Stanley & Co. LLC, and Cowen and Company, LLC, as representatives of the several underwriters named therein","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1299130/000110465923007513/0001104659-23-007513-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"Goldman Sachs & Co. LLC, Morgan Stanley & Co. LLC, and Cowen and Company, LLC, as representatives of the several underwriters named therein"},{"label":"Value","value":"approximately $189.2 million"},{"label":"Effective","value":"2023-01-24"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}